ClinicalTrials.Veeva

Menu

Effects of THC on Alcohol Consumption and Neural Correlates of Reward

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status and phase

Enrolling
Phase 2

Conditions

Cannabis Use Disorder

Treatments

Drug: Placebo
Drug: Dronabinol Pill

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06446479
22-1314

Details and patient eligibility

About

Alcohol and cannabis are often used together such that their effects overlap, but little is known about the neural mechanisms that underlie simultaneous use. High doses of THC have not been well-studied in the laboratory, and it is unclear how high doses of THC may impact alcohol consumption patterns. The proposed study will explore the effects of oral THC (20mg dronabinol) vs. placebo on neural reward, alcohol self-administration and naturalistic co-use patterns.

Full description

Participants will undergo a screening assessment, baseline session and two laboratory visits. The laboratory visits will involve an MRI scan and the opportunity to consume alcohol in our BAR lab. Prior to the MRI, participants will consume, a placebo (0mg) or high (20mg) dose of oral THC (dronabinol). Visits will be separated by 7 to 14 days. Dronabinol is an FDA-approved product that will be dispensed by our on-campus pharmacy

Enrollment

28 estimated patients

Sex

All

Ages

21 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Drink alcohol
  • Use cannabis
  • Contact site for additional details

Exclusion criteria

  • MRI contraindications (implanted metal, weight > 315 lb, etc.).
  • Contact site for additional details

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

28 participants in 2 patient groups

Placebo first, Dronabinol second
Experimental group
Description:
This arm will receive placebo on the first visit, and dronabinol on the second visit
Treatment:
Drug: Dronabinol Pill
Drug: Placebo
Dronabinol first, Placebo second
Experimental group
Description:
This arm will receive dronabinol on the first visit, and placebo on the second visit.
Treatment:
Drug: Dronabinol Pill
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Elnaz Nourollahimoghadam

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems